Page 101 - Tata_Chemicals_yearly-reports-2017-18
P. 101

Differentiated product offerings and targeted communication is   ANALYSIS OF FINANCIAL PERFORMANCE
          being used to address the threat from the unbranded segment and
                                                              Standalone performance for the year ended 31 March, 2018
          from regional and local brands.
                                                              Statement of Profit and Loss – Continuing operations
          Risks and Concerns
          The business has put policies in place to mitigate risks from changes   1.   Revenue from operations (net):
          in the regulatory environment which might limit realisations. There
                                                                                                         ` in crore
          are continuous improvement efforts to exploit efficiencies in the
                                                              Particulars        Year ended  Year ended   Change   %
          supply chain network to mitigate rising costs of labour and fuel.
                                                                                 31 March,  31 March,    Change
          Nutritional Solutions                                                    2018     2017
                                                              Revenue from operations   3,524   3,837   (313)   (8)
          The growth of Nutritional Solutions, which began with an idea in
                                                              Less: Excise duty on sale of
          our lab by a team of passionate scientists which, after intensive work
                                                              goods                    (58)    (230)   172   (75)
          and effort over the last four years is now transformed into a plant
                                                              Revenue from operations
          in Sriperumbudur, Chennai and investments in Mambattu, Nellore                                            Integrated Report
                                                              (net)                  3,466    3,607   (141)   (4)
          for manufacturing of Prebiotics [Short chain Fructo-oligosaccharide
                                                              Revenue from operations (net) decreased due to lower volumes of
          (‘FOS’) and Galacto-oligosaccharide (‘GOS’)]. The business, driven by
                                                              soda ash, salt, pulses and spices as well as lower realisation of pulses.
          science understanding and customer engagements, to become a
          leading nutritional innovation across various dimensions of human   2.  Other income:
          health.  The Nutritional Solutions business is motivated to provide
                                                                                                         ` in crore
          a significant improvement in the quality of life of our customers
          through innovative solutions.                       Particulars        Year ended  Year ended  Change   %
                                                                                  31 March,  31 March,   Change
          Leveraging TCL’s knowledge in at-scale fermentation, food technology,    2018     2017
          material sciences, biotechnology and biogenomics, the Company’s   Other income  194  177    17     10
          offerings cater to multiple end segments in the field of gut microbiota
                                                              Other income has increased mainly due to Gain on sale/redemption
          modulation and customised health solutions.
                                                              of investments.
          FY 2017-18 was yet another milestone year in terms of investments
          in infrastructure and capabilities.  With a committed capital outlay   3.   Cost of materials consumed:   Statutory Reports
          of ` 270 crore, the construction of our world-class 5,000 tonnes per
                                                                                                         ` in crore
          annum manufacturing plant at Mambattu, Nellore, Andhra Pradesh is
                                                              Particulars        Year ended  Year ended   Change   %
          on schedule. The business has built capabilities in IPR clinical studies,
                                                                                  31 March,  31 March,   Change
          product conceptualisation through customer partnership, complex          2018     2017
          fermentation technologies and gut microbiome data models.   Cost of materials consumed  531  480  51  11
          Operations at Sriperumbudur remained stable and the plant
                                                              Cost of materials is higher due to increase input costs of raw materials
          supported the increased customer demand by producing higher
                                                              comprising of coke, coal and anthracite.
          quantities across multiple grades of FOS. Project execution at
          Nellore is underway with ground-breaking ceremony performed   4.   Purchases of stock-in-trade:
          in November 2017. While sales of FOS and GOS continue to remain
                                                                                                         ` in crore
          buoyant, our newly introduced product offerings also found wide
                                                              Particulars        Year ended  Year ended   Change   %
          acceptance across various customer segments in food and beverages,
                                                                                 31 March,  31 March,    Change
          infant nutrition, nutraceuticals, pharmaceuticals and animal nutrition.
                                                                                   2018    2017
          A gross total of 1,700 tonnes of products were sold in India to 600+   Purchases of stock-in-trade  219  449  (230)  (51)
          customers across 105 cities. To support the upcoming expansion, the                                       Financial Statements
                                                              Purchases of stock-in-trade decreased mainly due to pulse business
          business is in the process of setting up of an international distribution
          network for select markets.                         towards reconfiguration of supply chain management.
          FERTILISER BUSINESS (DISCONTINUED OPERATIONS)       5.   Power and fuel:
          The Company divested its Urea and Customised Fertiliser business                               ` in crore
          situated at Babrala, Uttar Pradesh to Yara India effective 12 January,   Particulars  Year ended  Year ended   Change   %
          2018.  During the year under review, the Company also entered into a    31 March,  31 March,   Change
          Business Transfer Agreement with IRC Agrochemicals Private Limited       2018     2017
          for the sale of its Phosphatic Fertilisers business and the  Trading   Power and fuel  474  378  96  25
          business situated at Haldia, West Bengal subject to certain regulatory
                                                              The increase in power and fuel cost is mainly due to coal and pet coke
          and other approvals. In view of the same, the MDA does not include
                                                              price increase.
          an analysis of the Fertiliser business.

                                                                           Management Discussion and Analysis  99
   96   97   98   99   100   101   102   103   104   105   106